Clinical Trials
1
Active:1
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)IMX-110 in Patients With Advanced Solid Tumors
Phase 1
Active, not recruiting
- Conditions
- Solid Tumor, AdultAdvanced Solid TumorsBreast CancerOvarian CancerPancreatic Cancer
- Interventions
- First Posted Date
- 2017-12-22
- Last Posted Date
- 2023-09-28
- Lead Sponsor
- Immix Biopharma Australia Pty Ltd
- Target Recruit Count
- 70
- Registration Number
- NCT03382340
- Locations
- 🇺🇸
Sarcoma Oncology Research Center, Santa Monica, California, United States
🇦🇺St George Hospital, Sydney, New South Wales, Australia
News
No news found